"Ubiquitin Thiolesterase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thioester hydrolase which acts on esters formed between thiols such as DITHIOTHREITOL or GLUTATHIONE and the C-terminal glycine residue of UBIQUITIN.
| Descriptor ID |
D043222
|
| MeSH Number(s) |
D08.811.037.500 D08.811.277.352.897.850 D12.776.637.937
|
| Concept/Terms |
Ubiquitin Thiolesterase- Ubiquitin Thiolesterase
- Thiolesterase, Ubiquitin
- Ubiquitin C-Terminal Hydrolase
- C-Terminal Hydrolase, Ubiquitin
- Hydrolase, Ubiquitin C-Terminal
- Ubiquitin C Terminal Hydrolase
- Ubiquitin Carboxy-Terminal Hydrolase
- Carboxy-Terminal Hydrolase, Ubiquitin
- Hydrolase, Ubiquitin Carboxy-Terminal
- Ubiquitin Carboxy Terminal Hydrolase
- Ubiquitin C-Terminal Esterase
- C-Terminal Esterase, Ubiquitin
- Esterase, Ubiquitin C-Terminal
- Ubiquitin C Terminal Esterase
- Ubiquitin Carboxy-Terminal Esterase
- Carboxy-Terminal Esterase, Ubiquitin
- Esterase, Ubiquitin Carboxy-Terminal
- Ubiquitin Carboxy Terminal Esterase
Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1- Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1
- Ubiquitin Carboxyl Terminal Hydrolase Isozyme L1
- Parkinson Disease 5 Protein
- PARK5 Protein
- Neuron Cytoplasmic Protein 9.5
- UCHL1 Protein
- Uch-L1 Protein
- Uch L1 Protein
|
Below are MeSH descriptors whose meaning is more general than "Ubiquitin Thiolesterase".
Below are MeSH descriptors whose meaning is more specific than "Ubiquitin Thiolesterase".
This graph shows the total number of publications written about "Ubiquitin Thiolesterase" by people in this website by year, and whether "Ubiquitin Thiolesterase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 2 | 3 | 5 |
| 2019 | 2 | 3 | 5 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 0 | 1 |
| 2025 | 3 | 1 | 4 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ubiquitin Thiolesterase" by people in Profiles.
-
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database. J Thorac Oncol. 2026 Jul; 21(7):103681.
-
The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors. Hum Pathol. 2026 Jun; 172:106103.
-
Identification of targetable epigenetic vulnerabilities for uveal melanoma. Cell Death Dis. 2025 Dec 12; 17(1):89.
-
Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus. Nat Commun. 2025 Oct 02; 16(1):8795.
-
Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations. J Thorac Oncol. 2025 11; 20(11):1683-1698.
-
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations. J Thorac Oncol. 2025 11; 20(11):1615-1625.
-
Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury. JAMA Netw Open. 2024 09 03; 7(9):e2431115.
-
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. Nat Genet. 2024 Jan; 56(1):27-36.
-
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
-
UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1. Cells. 2023 10 05; 12(19).